Longeveron (LGVN) Other Non-Current Assets (2021 - 2026)

Longeveron's (LGVN) quarterly Other Non-Current Assets came in at $18000.0 in Q1 2026, down 91.04% year-on-year from $201000.0 in Q1 2025, and down 89.77% quarter-over-quarter from $176000.0 in Q4 2025.

Longeveron (LGVN) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Longeveron's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $18000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 91.04% year-over-year to $18000.0 in Q1 2026; TTM through Mar 2026 was $18000.0, a 91.04% decrease from a year earlier, with the FY2025 full-year figure at $176000.0, down 12.87% from the prior year.
  • Other Non-Current Assets declined to $18000.0 in Q1 2026 per LGVN's latest filing, from $176000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $247000.0 in Q1 2023 and bottomed at $18000.0 in Q1 2026.
  • The 5-year median for Other Non-Current Assets is $200500.0 (2025), against an average of $191142.9.
  • Across the five-year window, Other Non-Current Assets soared 37.85% in 2022 and tumbled 91.04% in 2026, its largest moves.
  • Year by year, Other Non-Current Assets stood at $244000.0 in 2022, then fell by 20.9% to $193000.0 in 2023, then rose by 4.66% to $202000.0 in 2024, then fell by 12.87% to $176000.0 in 2025, then tumbled by 89.77% to $18000.0 in 2026.
  • Per Business Quant, the three latest LGVN Other Non-Current Assets figures stand at $18000.0 (Q1 2026), $176000.0 (Q4 2025), and $178000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Longeveron 3.97 Mn -11.79 Mn 264,000.00 18,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 18,000.00
Dec 31, 2025 176,000.00
Sep 30, 2025 178,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 201,000.00
Dec 31, 2024 202,000.00
Sep 30, 2024 203,000.00
Jun 30, 2024 204,000.00
Mar 31, 2024 190,000.00
Dec 31, 2023 193,000.00
Sep 30, 2023 197,000.00
Jun 30, 2023 223,000.00
Mar 31, 2023 247,000.00
Dec 31, 2022 244,000.00
Dec 31, 2021 177,000.00